Risk & reward: Longevity investmentsAuthor: Phil Newman | Last updated: April 30, 2020 Ronjon NagManaging Director and Founder, R42 GroupRisk & reward: longevity investments No spam - just the good stuffSubscribe to our newsletter Share this article: Editor's choiceEmpowering cells to boost energy and recovery is a winning moveStudy disproves benefits of probiotics for vaginal healthHow do Tour De France athletes recover so fast? Performance coach reveals the secret9 proven ways to beat brain fog and enhance your energyLongevity investment platform opens-up to international investorsUrolithin A research opens door to osteoarthritis reliefPopular articlesColossal Biosciences spin out Form Bio lands $30 million for breakthrough computational life sciences platformHalberd enters strategic alliance for longevity and Alzheimer’s diseaseBiomanufacturing to reduce the cost of regenerative medicineFasting-mimicking diet reduces signs of dementia in miceUnderstanding the biology of aging and age-related pathologiesPhase 3 trial shows Alzheimer’s drug slows progression of disease
